All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

hiv & aids news selected from other sources

  • Women
    Study to investigate how sexual trauma increases HIV susceptibility in women
    Eurekalert Inf Dis | 05 March 2019

    Novel study to investigate how sexual trauma increases HIV susceptibility in women.

  • Undetectable viral load and treatment as prevention
    HIV prevention study finds universal 'test and treat' approach can reduce new infections
    NIH/National Institute of Allergy and Infectious Diseases | 05 March 2019

    New HIV infections declined by 30 percent in southern African communities where health workers conducted house-to-house voluntary HIV testing, referred people who tested positive to begin HIV treatment according to local guidelines, and offered other proven HIV prevention measures to those who tested negative. Local guidelines evolved during the study from offering HIV treatment based on immune health to offering immediate treatment for all.

  • PrEP
    Should the NIH Break HIV Prevention Drug Truvada's Patent?
    Fortune | 05 March 2019

    Should a biotech giant holding a valuable patent be forced to give it up if doing so would serve the public good? That’s the mounting debate over Gilead Sciences’ hold on an HIV prevention treatment, which some say is too expensive and should be available to all.

  • Undetectable viral load and treatment as prevention
    'Test and Treat' reduces new HIV infections by a third in African communities
    Imperial College London | 05 March 2019

    New HIV infections in southern Africa could be reduced substantially by offering entire communities voluntary HIV testing, and immediately referring those who test positive for HIV treatment in line with local guidelines, according to new research presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, USA today.

  • Epidemiology
    Which Neighborhood Factors Predict Viral Suppression in Heterosexuals?
    Poz | 05 March 2019

    Researchers measured various neighborhood characteristics against viral suppression rates among heterosexuals with HIV in New York City.

  • Government, leadership and policy
    Ireland: The new HIV crisis needs a better response
    Irish Times | 04 March 2019

    HIV is a public heath issue, but a spike in diagnoses in Ireland seems to be going unchecked. New figures published last week show there were 531 new cases of HIV infections diagnosed in 2018, an increase from 492 in 2017. There is now a new diagnosis of HIV in Ireland every 17 hours; Ireland’s rate of new diagnoses stood at 10.2 per 100,000 people in 2017, while the European average is 6.2 per 100,000.

  • Sexually transmitted infections prevention
    Why are black and minority ethnic girls less likely to get the HPV jab? (Video)
    BBC | 04 March 2019

    The HPV - or Human Papilloma Virus - vaccine is available to year 8 and 9 schoolgirls across Britain. But not all of them get the jab. Girls from black, Asian or minority ethnic (BAME) backgrounds are less likely to receive the vaccine in school than their white counterparts.

  • Retention and linkage to care
    San Francisco Is Beating H.I.V. Why Can’t Houston?
    The New York Times | 04 March 2019

    We know how to fight the epidemic, but patients in the South still aren’t getting the treatment they need.

  • PrEP
    Examining the Truvada #BreakThePatent Debate: Gilead Responds
    IPWatchdog.com | 04 March 2019

    A review of how patents affect access to Truvada, and Gilead's response on calls for march-in rights to be granted on patents in order to facilitate access.

  • Pharmaceutical industry
    Hepatitis C Treatment Market to Exceed US$ 71.13 Bn by the end of 2024
    Honest Businessman | 04 March 2019

    The global hepatitis C treatment market was valued at US$ 23.9 Bn in 2015 and is estimated to be valued at US$ 26.6 Bn by 2016. The market is expected to reach a valuation of US$ 71.13 Bn by the end of 2024, reflecting a cumulative annual growth rate of 13.1% over the forecast period.

Conference news

News from the Conference on Retroviruses and Opportunistic Infections (CROI 2019).

aidsmapLIVE

Watch our AIDS 2018 aidsmapLIVE panel discussion on YouTube.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

New EUROBulletin

Read the December edition of the Sexual Health & HIV Policy EUROBulletin.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.